Acuta Capital Partners, LLC Acer Therapeutics Inc. Transaction History

Acuta Capital Partners, LLC

  • $98.8 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$3.45 - $26.86 $507,150 - $3.95 Million
-147,000 Closed
0 $0
Q1 2019

May 14, 2019
BUY
$20.4 - $25.15 $81,600 - $100,600
4,000 Added 2.8%
147,000 $3.57 Million
Q4 2018

Feb 14, 2019
BUY
$16.55 - $30.22 $558,231 - $1.02 Million
33,730 Added 30.87%
143,000 $2.88 Million
Q2 2018

Aug 15, 2018
BUY
$17.71 - $21.6 $1.94 Million - $2.36 Million
109,270 New
109,270 $2.36 Million

Others Institutions Holding ACER

# of Institutions
1
Shares Held
365
Call Options Held
0
Put Options Held
0
View Full List

About Acer Therapeutics Inc.

ACER Quotes by TradingView
  • Ticker ACER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,100,000
  • Description
  • Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...
More about ACER
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email